Tolerance of Other Carbonic Anhydrase Inhibitors in a Patient With Dorzolamide‐Induced Allergic Contact Dermatitis
In the last 3 years, Ignacio Dávila has received payment for lectures, including service on speaker's bureaus from Allergy Therapeutics, ALK, Astra-Zeneca, Chiesi, Diater, GSK, Leti, Novartis, Sanofi; for a consultancy from Allergy Therapeutics, ALK-Abello, Astra-Zeneca, GSK, Merck, MSD, Novartis, Sanofi; and grants from Thermo Fisher Diagnostics, ISCIII and Junta de Castilla y León. The remaining authors declare no conflicts of interest.
Authors
- Esther Moreno (ORCID: https://orcid.org/0000-0003-0953-3025)
- I. Dávila-González
- Elena Mazoteras‐Martínez (ORCID: https://orcid.org/0009-0006-8749-3304)
- María Nerea Otero‐Fernández (ORCID: https://orcid.org/0009-0003-0981-4545)
- Elena Laffond‐Yges
- Adelaida Cabrera‐Núñez
- Egleé Elena Muñoz‐Díaz (ORCID: https://orcid.org/0009-0008-7052-5810)
Institutions
- Universidad de Salamanca (ES)
- Instituto de Salud Carlos III (ES)
- Complejo Hospitalario de Salamanca (ES)
- Instituto de Investigación Biomédica de Salamanca (ES)
Publication Details
- Journal
- Contact Dermatitis
- Published
- 2025-05-01
- DOI
- https://doi.org/10.1111/cod.14809
- Primary Topic
- Contact Dermatitis and Allergies
- Type
- article
- Field-Weighted Citation Impact
- 0.00